In A549 and HCC-15 cells, RESV reduced LC resistance to tumor necrosis factor-related apoptosis-inducing ligand by inhibiting the Akt/NF-κB pathway (69). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.